June 2008 BPA Statement
Nemolizumab for Atopic Dermatitis Shows Positive Results in Phase 3 Trials
Galderma said the FDA has accepted the company’s Biologics License Application for the therapy based on data from the trials.
Podcast: Discussing the Shared Central Fulfillment Solution with iA
Drug Topics sits down with iA to discuss its new shared central fulfillment solution.
Q&A: Discovering the Powerful Impact of Community Pharmacy
In part 3 of his conversation with Drug Topics on Over the Counter, Mayank Amin, PharmD, RPh, MBA, continues his inspiring story of reopening Skippack Pharmacy and details the beginnings of The Superman Pharmacist.
Is E-Prescribing the Future of Veterinary Medicine?
Wendy Crouse, DVM, an independent house call veterinarian with Heal House Call Veterinarian, sat down with Drug Topics to discuss how the adoption of e-prescribing has transformed her practice.
Lenacapavir for PrEP Shows 100% Efficacy in Preventing HIV
Full efficacy and safety results for the phase 3 PURPOSE 1 trial were announced by Gilead at AIDS 2024.
Democrats, Republicans Come Together to Condemn PBMs
In a House Committee on Oversight and Accountability hearing, Democrats and Republicans took a bipartisan stance to question the role major PBMs play regarding rising drug costs in the US.
